BackAcorda Therapeutics Overview

Acorda Therapeutics Net Income

Profitability analysis for ACOR.

Quarterly Net Income

-$27.39M
↓ 62.83% YoY

As of Mar 2024

Annual Net Income (TTM)

-$263.43M
↓ 352.48% YoY

Trailing 12 months ending Mar 2024

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin